[1] Your GP can assess whether side effects are manageable with supportive measures, require dose adjustment, or necessitate discontinuation of treatment
These drugs are being used for cosmetic reasons for non-obese patients, exclusively prescribed through telemedicine, or being prescribed by providers who have never managed obesity before and may not be qualified to be prescribing them. Dr
A little background: In May 2025, Novo Nordisk, the maker of Rybelsus, Wegovy, and Ozempic, applied for FDA approval of an oral version of Wegovy
Patients should seek immediate medical attention if they experience difficulty swallowing, speaking or breathing following treatment
Book Semaglutide Consultation A Street in South Boston Book Semaglutide Consultation L Street in South Boston Call Us to Learn More (800-905-4252)